Drilldown: Medicines

3-MMC (1) · Alprazolam (1) · Bromazepam (1) · Butylone (1) · Cathinone (1) · Chlordiazepoxide (1) · Clobazam (1) · Clonazolam (1) · Clorazepate (1) · Cyproheptadine (hydrochloride) (1) · Diclazepam (1) · Ephylone (1) · Estazolam (1) · Ethcathinone (1) · Ethylone (1) · Flualprazolam (1) · Flubromazepam (1) · Flubromazolam (1) · Flunitrazepam (1) · Flunitrazolam (1) · Flurazepam (1) · Hexedrone (1) · Lormetazepam (1) · Mephedrone (1) · Methcathinone (1) · Methylone (1) · Mexedrone (1) · Midazolam (1) · N-Ethylhexedrone (1) · N-Ethylpentedrone (1) · Nifoxipam (1) · Nitrazepam (1) · Oxazepam (1) · Pentedrone (1) · Pyrazolam (1) · Quazepam (1) · Temazepam (1) · Triazolam (1)

None (23) · Dalmane (1) · Doral (1) · Halcion (1) · Lexotan (1) · Librium (1) · Mogadon (1) · Onfi (1) · Periactin (US brand discontinued; generic widely available) (1) · ProSom (1) · Restoril (1) · Rohypnol (1) · Serax (1) · Tranxene (1) · Versed (1) · Xanax (1)

Research material · Classic Psychedelic · Stimulant · Opioid · Sedative-Hypnotic · Phenethylamine · Tryptamine · Benzodiazepine · Botanical · [[:Category:Antihypertensives|Antihypertensive]] · Dissociative · Anticonvulsant · Antidepressant · Plant Medicine · Analgesic · Antipsychotic · Antiparkinsonian · Empathogen · Neuroleptic · Cathinone

Other values:

Search

Cathinone analogue; monoamine reuptake inhibitor (2) · Extremely potent GABAA positive allosteric modulator (1) · GABA-A positive allosteric modulator'"`UNIQ--ref-00000067-QINU`"' '"`UNIQ--vote-00000068-QINU`"' (1) · GABAA positive allosteric modulator (18) · GABAA positive allosteric modulator; low sedation (1) · GABAA positive allosteric modulator; prodrug of desmethyldiazepam (1) · GABAA positive allosteric modulator; very long half-life (1) · Monoamine releasing agent (4) · Monoamine releasing agent; active ingredient in khat (1) · Norepinephrine and dopamine releasing agent (1) · Norepinephrine/dopamine releasing agent (1) · Norepinephrine/dopamine reuptake inhibitor (1) · Serotonin releasing agent; monoamine reuptake inhibitor (1) · Serotonin/norepinephrine/dopamine releasing agent (3) · '"`UNIQ--vote-00000017-QINU`"' Anticholinergic and sedating, with the standard first-generation antihistamine Beers-list concerns in elderly patients'"`UNIQ--ref-00000018-QINU`"'. (1)

None (36) · '"`UNIQ--vote-00000019-QINU`"', '"`UNIQ--vote-0000001A-QINU`"', '"`UNIQ--vote-0000001B-QINU`"', '"`UNIQ--vote-0000001C-QINU`"', '"`UNIQ--vote-0000001D-QINU`"' (1) · '"`UNIQ--vote-00000069-QINU`"', '"`UNIQ--vote-0000006A-QINU`"', '"`UNIQ--vote-0000006B-QINU`"' (1)

None (36) · 0.25 mg (1) · Allergy: 4 mg PO TID. Serotonin syndrome: 12 mg loading dose PO or by nasogastric tube, then 2 mg every 2 hours until clinical improvement. Appetite stimulation: 2-4 mg PO TID-QID (1)

None (36) · 0.25 mg, 0.5 mg, 1 mg, 2 mg tablets (immediate-release and orally disintegrating); 0.5 mg, 1 mg, 2 mg, 3 mg extended-release tablets; 1 mg/mL oral concentrate (1) · Tablets 4 mg; oral syrup 2 mg/5 mL (1)

None (36) · 10 mg/d (1) · 32 mg/day adult; weight-based pediatric ceiling (1)

None (36) · Oral (2)

None (36) · 30-60 min (immediate-release); 1-2 h (extended-release) (1) · 30-60 minutes (1)

None (36) · 6 h (immediate-release); ~11 h (extended-release) (1) · 6-8 hours (1)

None (36) · 11-13 h (immediate-release); 11-16 h (extended-release) (1) · 8-16 hours'"`UNIQ--ref-0000001E-QINU`"' (1)

None (36) · 80-90% oral (1) · ~95% (oral)'"`UNIQ--ref-0000001F-QINU`"' (1)

None (36) · Category D'"`UNIQ--ref-0000006C-QINU`"' (1) · Limited human data; older agent with substantial use experience.<sup class="pcp-cn" title="This claim needs a citation.">&#91;[[Pharmacopedia:Citation needed|citation&nbsp;needed]]&#93;</sup> (1)

None (36) · Schedule IV (US) (1) · [[USLegal:Prescription only|Rx-only]] in US (1)